What is it?


Valeriana officinalis, commonly referred to as Valerian root, is a medicinal herb found in North America, Asia, and Europe that has been traditionally used to treat sleep and anxiety disorders.  Valerian contains more than 150 phytochemicals, and valerian extracts are most often standardized by their valeric acid content. However, it is not fully known which constituents are primarily responsible for its effects. (26)(31)(54) Valerian’s mechanism of action is not completely understood but may be due to its stimulation of GABA transmission via positive modulation of GABA-A receptors, (7)(33) similarly to benzodiazepines (a class of sedatives). (31) However, valerian may possess certain advantages over benzodiazepines and other conventional sedatives, including lower rates of adverse events. (18)(27)(59) For example, valerian may not impair alertness, concentration, or reaction time upon awakening, (35) impair machine operation and driving ability, (22)(57) or exhibit the same extent of clinically relevant interactions with other pharmaceuticals. It is important to note, however, that valerian may theoretically have additive effects if administered in combination with other sedatives. (26)(31)

Main uses

Anxiety and stress
Behavioral and nervous system regulation
Insomnia and sleep disturbance
Premenstrual, menstrual, and postmenopausal symptoms


Dormeasan ®
Tincture containing 460 mg valerian root at a drug extract ratio (DER) of 1:10 and 460 mg of Humulus lupulus at a DER of 1:12, both of which are dissolved in 61% ethanol (15)
LI 156 (Sedonium®)
Contains 300 mg dry root extract of at a DER of 3-6:1 (14)
Contains 300 mg valerian standardized to 0.8% valerenic acid, 30 mg Humulus lupulus standardized to 0.35% rutin, and 80 mg Passiflora incarnata standardized to 4% isovitexin in a 410 mg tablet (38)
Songha Night™
Contains 120 mg of valerian extract at a DER of 4.5:1 and 80 mg of Melissa officinalis extract at a DER of 5:1 (32)
Valdispert ® forte
Contains 135 mg of aqueous alkaline dried valerian root extract with DER of 5-6:1 (52)
Ze 185 (Relaxane®)
Contains 90 mg of a 55% methanolic valerian root extract at a DER of 5-8:1, 90 mg of a 90% ethanolic Petasites hybridus root extract at a DER of 7-14:1, 90 mg of a 50% ethanolic Passiflora incarnata herbal extract at a DER of 3-6:1, and 60 mg of a 20% ethanolic Melissa officinalis leaf extract at a DER of 3.5-5.5:1 (40)
Ze 91019
Contains 250 mg of a 45% methanolic valerian root extract at a DER of 4-6:1 and 60 mg of Humulus lupulus extract at a DER of 5-7:1 (34)(58)

Dosing & administration

Adverse effects

Reported side effects may include headaches, gastrointestinal distress, nausea, diarrhea, sweating, dizziness, drowsiness, or other psychological effects such as feelings of isolation, brain fog, depression, or irritability. Valerian does not appear to have an increased risk of any severe side effects compared to other pharmaceutical treatments or placebo groups. (8)(56) However, the likelihood of experiencing multiple adverse events per patient may be greater than placebo. (36)



  • Valerenic acid max serum concentration occurs between 1-2 hours in healthy adults with large interindividual variability (range 0.5-4 hours) (2)(3)
  • Similar absorption speed occurs with single- or multiple-doses (3)


  • Valerenic acid in serum measurable for at least five hours in healthy adults (2)


  • Low doses (125 mg three times per day) did not inhibit CYP2D6, CYP1A2, CYP3A4/5, or CYP2E1 in humans (25)
  • High doses (500 mg twice per day) mildly inhibited CYP2D6, but not likely in a clinically relevant fashion and had no effect on CYP3A4 in humans (17)


  • Valerenic acid’s half-life was approximately one hour in healthy adults (2)(3)
  • Similar elimination rate occurs with single- or multiple-doses, but elimination rate may be positively correlated with body weight indicating that higher range doses may be required for individuals with increased body weight (3)


Last updated: September 14th, 2020

  1. Ahmadi, M., Khalili, H., Abbasian, L., & Ghaeli, P. (2017). Effect of valerian in preventing neuropsychiatric adverse effects of efavirenz in hiv-positive patients: A pilot randomized, placebo-controlled clinical trial. The Annals of Pharmacotherapy, 51(6), 457–464. ()
  2. Anderson, G. D., Elmer, G. W., Kantor, E. D., Templeton, I. E., & Vitiello, M. V. (2005). Pharmacokinetics of valerenic acid after administration of valerian in healthy subjects. Phytotherapy Research, 19(9), 801–803. ()
  3. Anderson, G. D., Elmer, G. W., Taibi, D. M., Vitiello, M. V., Kantor, E., Kalhorn, T. F., Howald, W. N., Barsness, S., & Landis, C. A. (2010). Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women. Phytotherapy Research, 24(10), 1442–1446. ()
  4. Andreatini, R., Sartori, V. A., Seabra, M. L. V., & Leite, J. R. (2002). Effect of valepotriates (valerian extract) in generalized anxiety disorder: A randomized placebo-controlled pilot study. Phytotherapy Research, 16(7), 650–654. ()
  5. Barton, D. L., Atherton, P. J., Bauer, B. A., Moore, D. F., Jr, Mattar, B. I., Lavasseur, B. I., Rowland, K. M., Jr, Zon, R. T., Lelindqwister, N. A., Nagargoje, G. G., Morgenthaler, T. I., Sloan, J. A., & Loprinzi, C. L. (2011). The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: A phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5). The Journal of Supportive Oncology, 9(1), 24–31. ()
  6. Behboodi Moghadam, Z., Rezaei, E., Shirood Gholami, R., Kheirkhah, M., & Haghani, H. (2016). The effect of Valerian root extract on the severity of pre menstrual syndrome symptoms. African Journal of Traditional, Complementary, and Alternative Medicines, 6(3), 309–315. ()
  7. Benke, D., Barberis, A., Kopp, S., Altmann, K.-H., Schubiger, M., Vogt, K. E., Rudolph, U., & Möhler, H. (2009). GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology, 56(1), 174–181. ()
  8. Bent, S., Padula, A., Moore, D., Patterson, M., & Mehling, W. (2006). Valerian for sleep: A systematic review and meta-analysis. The American Journal of Medicine, 119(12), 1005–1012. ()
  9. Circosta, C., De Pasquale, R., Samperi, S., Pino, A., & Occhiuto, F. (2007). Biological and analytical characterization of two extracts from Valeriana officinalis. Journal of Ethnopharmacology, 112(2), 361–367. ()
  10. Cropley, M., Cave, Z., Ellis, J., & Middleton, R. W. (2002). Effect of kava and valerian on human physiological and psychological responses to mental stress assessed under laboratory conditions. Phytotherapy Research: PTR, 16(1), 23–27. ()
  11. Cuellar, N. G., & Ratcliffe, S. J. (2009). Does valerian improve sleepiness and symptom severity in people with restless legs syndrome? Alternative Therapies in Health and Medicine, 15(2), 22–28. ()
  12. Culpepper, L., & Wingertzahn, M. A. (2015). Over-the-counter agents for the treatment of occasional disturbed sleep or transient insomnia: A systematic review of efficacy and safety. The Primary Care Companion to CNS Disorders, 17(6). ()
  13. Del Valle-Mojica, L. M., Cordero-Hernández, J. M., González-Medina, G., Ramos-Vélez, I., Berríos-Cartagena, N., Torres-Hernández, B. A., & Ortíz, J. G. (2011). Aqueous and ethanolic Valeriana officinalis extracts change the binding of ligands to glutamate receptors. Evidence-Based Complementary and Alternative Medicine, 2011, 891819. ()
  14. Diaper, A., & Hindmarch, I. (2004). A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults. Phytotherapy Research: PTR, 18(10), 831–836. ()
  15. Dimpfel, W., & Suter, A. (2008). Sleep improving effects of a single dose administration of a valerian/hops fluid extract - A double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms. European Journal of Medical Research, 13(5), 200–204. ()
  16. Donath, F., Quispe, S., Diefenbach, K., Maurer, A., Fietze, I., & Roots, I. (2000). Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry, 33(2), 47–53. ()
  17. Donovan, J. L., DeVane, C. L., Chavin, K. D., Wang, J.-S., Gibson, B. B., Gefroh, H. A., & Markowitz, J. S. (2004). Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 32(12), 1333–1336. ()
  18. Dorn, M. (2000). [Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: A randomised, double-blind, clinical, comparative study]. Research in Complementary and Natural Classical Medicine, 7(2), 79–84. ()
  19. Farah, G. J., Ferreira, G. Z., Danieletto-Zanna, C. F., Luppi, C. R., & Jacomacci, W. P. (2019). Assessment of Valeriana officinalis l. (valerian) for conscious sedation of patients during the extraction of impacted mandibular third molars: A randomized, split-mouth, double-blind, crossover study. Journal of Oral and Maxillofacial Surgery, 77(9), 1796.e1–e1796.e8. ()
  20. Fernández-San-Martín, M. I., Masa-Font, R., Palacios-Soler, L., Sancho-Gómez, P., Calbó-Caldentey, C., & Flores-Mateo, G. (2010). Effectiveness of Valerian on insomnia: A meta-analysis of randomized placebo-controlled trials. Sleep Medicine, 11(6), 505–511. ()
  21. Francis, A. J. P., & Dempster, R. J. W. (2002). Effect of valerian, Valeriana edulis, on sleep difficulties in children with intellectual deficits: Randomised trial. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 9(4), 273–279. ()
  22. Gerhard, U., Linnenbrink, N., Georghiadou, C., & Hobi, V. (1996). [Vigilance-decreasing effects of 2 plant-derived sedatives]. Praxis, 85(15), 473–481. ()
  23. Gharib, M., Samani, L. N., Panah, Z. E., Naseri, M., Bahrani, N., & Kiani, K. (2015). The effect of valeric on anxiety severity in women undergoing hysterosalpingography. Global Journal of Health Science, 7(3), 358–363. ()
  24. Guadagna, S., Barattini, D. F., Rosu, S., & Ferini-Strambi, L. (2020). Plant extracts for sleep disturbances: A systematic review. Evidence-Based Complementary and Alternative Medicine, 2020, 3792390. ()
  25. Gurley, B. J., Gardner, S. F., Hubbard, M. A., Williams, D. K., Gentry, W. B., Khan, I. A., & Shah, A. (2005). In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clinical Pharmacology and Therapeutics, 77(5), 415–426. ()
  26. Hadley, S. K., & Petry, J. J. (2003). Valerian. American Family Physician, 67(8), 1755–1758. ()
  27. Hallam, K. T., Olver, J. S., McGrath, C., & Norman, T. R. (2003). Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers. Human Psychopharmacology, 18(8), 619–625. ()
  28. Hassani, S., Alipour, A., Darvishi Khezri, H., Firouzian, A., Emami Zeydi, A., Gholipour Baradari, A., Ghafari, R., Habibi, W.-A., Tahmasebi, H., Alipour, F., & Ebrahim Zadeh, P. (2015). Can Valeriana officinalis root extract prevent early postoperative cognitive dysfunction after CABG surgery? A randomized, double-blind, placebo-controlled trial. Psychopharmacology, 232(5), 843–850. ()
  29. Jenabi, E., Shobeiri, F., Hazavehei, S. M. M., & Roshanaei, G. (2018). The effect of Valerian on the severity and frequency of hot flashes: A triple-blind randomized clinical trial. Women & Health, 58(3), 297–304. ()
  30. Kamranpour, S. B., Rahbar, T., Farzad Rik, L., & Alizadeh, S. (2015). The Effect of Valerian extract on the severity of psychological and behavioral symptoms of premenstrual syndrome. Complementary Medicine Journal, 4(4), 1012–1021. ()
  31. Kelber, O., Nieber, K., & Kraft, K. (2014). Valerian: No evidence for clinically relevant interactions. Evidence-Based Complementary and Alternative Medicine, 2014, 879396. ()
  32. Kennedy, D. O., Little, W., Haskell, C. F., & Scholey, A. B. (2006). Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytotherapy Research, 20(2), 96–102. ()
  33. Khom, S., Strommer, B., Ramharter, J., Schwarz, T., Schwarzer, C., Erker, T., Ecker, G. F., Mulzer, J., & Hering, S. (2010). Valerenic acid derivatives as novel subunit-selective GABAA receptor ligands - In vitro and in vivo characterization. British Journal of Pharmacology, 161(1), 65–78. ()
  34. Koetter, U., Schrader, E., Käufeler, R., & Brattström, A. (2007). A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Phytotherapy Research, 21(9), 847–851. ()
  35. Kuhlmann, J., Berger, W., Podzuweit, H., & Schmidt, U. (1999). The influence of valerian treatment on “reaction time, alertness and concentration” in volunteers. Pharmacopsychiatry, 32(6), 235–241. ()
  36. Leach, M. J., & Page, A. T. (2015). Herbal medicine for insomnia: A systematic review and meta-analysis. Sleep Medicine Reviews, 24, 1–12. ()
  37. Leathwood, P. D., Chauffard, F., Heck, E., & Munoz-Box, R. (1982). Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacology, Biochemistry, and Behavior, 17(1), 65–71. ()
  38. Maroo, N., Hazra, A., & Das, T. (2013). Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: A randomized controlled trial. Indian Journal of Pharmacology, 45(1), 34–39. ()
  39. Meier, S., Haschke, M., Zahner, C., Kruttschnitt, E., Drewe, J., Liakoni, E., Hammann, F., & Gaab, J. (2018). Effects of a fixed herbal drug combination (Ze 185) to an experimental acute stress setting in healthy men - An explorative randomized placebo-controlled double-blind study. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 39, 85–92. ()
  40. Melzer, J., Schrader, E., Brattström, A., Schellenberg, R., & Saller, R. (2009). Fixed herbal drug combination with and without butterbur (Ze 185) for the treatment of patients with somatoform disorders: Randomized, placebo-controlled pharmaco-clinical trial. Phytotherapy Research, 23(9), 1303–1308. ()
  41. Mirabi, P., Dolatian, M., Mojab, F., & Majd, H. A. (2011). Effects of valerian on the severity and systemic manifestations of dysmenorrhea. International Journal of Gynaecology and Obstetrics, 115(3), 285–288. ()
  42. Mirabi, P., & Mojab, F. (2013). The effects of valerian root on hot flashes in menopausal women. Iranian Journal of Pharmaceutical Research, 12(1), 217–222. ()
  43. Morin, C. M., Koetter, U., Bastien, C., Ware, J. C., & Wooten, V. (2005). Valerian-hops combination and diphenhydramine for treating insomnia: A randomized placebo-controlled clinical trial. Sleep, 28(11), 1465–1471. ()
  44. Nunes, A., & Sousa, M. (2011). [Use of valerian in anxiety and sleep disorders: What is the best evidence?]. Acta medica portuguesa, 24 Suppl 4, 961–966. ()
  45. Occhiuto, F., Pino, A., Palumbo, D. R., Samperi, S., De Pasquale, R., Sturlese, E., & Circosta, C. (2009). Relaxing effects of Valeriana officinalis extracts on isolated human non-pregnant uterine muscle. The Journal of Pharmacy and Pharmacology, 61(2), 251–256. ()
  46. Oxman, A. D., Flottorp, S., Håvelsrud, K., Fretheim, A., Odgaard-Jensen, J., Austvoll-Dahlgren, A., Carling, C., Pallesen, S., & Bjorvatn, B. (2007). A televised, web-based randomised trial of an herbal remedy (valerian) for insomnia. PloS One, 2(10), e1040. ()
  47. Pakseresht, S., Boostani, H., & Sayyah, M. (2011). Extract of valerian root (Valeriana officinalis L.) vs. placebo in treatment of obsessive-compulsive disorder: A randomized double-blind study. Journal of Complementary & Integrative Medicine, 8. ()
  48. Poyares, D. R., Guilleminault, C., Ohayon, M. M., & Tufik, S. (2002). Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26(3), 539–545. ()
  49. Roh, D., Jung, J. H., Yoon, K. H., Lee, C. H., Kang, L. Y., Lee, S.-K., Shin, K., & Kim, D. H. (2019). Valerian extract alters functional brain connectivity: A randomized double-blind placebo-controlled trial. Phytotherapy Research, 33(4), 939–948. ()
  50. Samaei, A., Nobahar, M., Hydarinia-Naieni, Z., Ebrahimian, A. A., Tammadon, M. R., Ghorbani, R., & Vafaei, A. A. (2018). Effect of valerian on cognitive disorders and electroencephalography in hemodialysis patients: A randomized, cross over, double-blind clinical trial. BMC Nephrology, 19(1), 379. ()
  51. Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13(2), 307–349. ()
  52. Schulz, H., Stolz, C., & Müller, J. (1994). The effect of valerian extract on sleep polygraphy in poor sleepers: A pilot study. Pharmacopsychiatry, 27(4), 147–151. ()
  53. Stevinson, C., & Ernst, E. (2000). Valerian for insomnia: A systematic review of randomized clinical trials. Sleep Medicine, 1(2), 91–99. ()
  54. Sundaresan, N., Narayanan, K. B., & Ilango, K. (2018). Valeriana officinalis: A review of its traditional uses, phytochemistry and pharmacology. Asian Journal of Pharmaceutical and Clinical Research, 11(1), 36–41. ()
  55. Taavoni, S., Ekbatani, N., Kashaniyan, M., & Haghani, H. (2011). Effect of valerian on sleep quality in postmenopausal women: A randomized placebo-controlled clinical trial. Menopause , 18(9), 951–955. ()
  56. Taibi, D. M., Landis, C. A., Petry, H., & Vitiello, M. V. (2007). A systematic review of valerian as a sleep aid: Safe but not effective. Sleep Medicine Reviews, 11(3), 209–230. ()
  57. Thomas, K., Canedo, J., Perry, P. J., Doroudgar, S., Lopes, I., Chuang, H. M., & Bohnert, K. (2016). Effects of valerian on subjective sedation, field sobriety testing and driving simulator performance. Accident; Analysis and Prevention, 92, 240–244. ()
  58. Vonderheid-Guth, B., Todorova, A., Brattström, A., & Dimpfel, W. (2000). Pharmacodynamic effects of valerian and hops extract combination (Ze 91019) on the quantitative-topographical EEG in healthy volunteers. European Journal of Medical Research, 5(4), 139–144. ()
  59. Ziegler, G., Ploch, M., Miettinen-Baumann, A., & Collet, W. (2002). Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study. European Journal of Medical Research, 7(11), 480–486. ()

Get more resources for your practice